Literature DB >> 320922

Comparisons of the complement-fixation and indirect fluorescent antibody reactions in the detection of bovine babesiasis.

K L Kuttler, L G Adams, R A Todorovic.   

Abstract

Complement-fixation (CF) and indirect fluorescent antibody (IFA) antigens were prepared from Babesia bigemina isolates obtained in Texas. These serologic procedures were evaluated on 130 serum samples sequentially collected from 5 B bigemina-infected mature cattle, beginning on the day of exposure and continuing for 175 day thereafter. Both tests were effective in detecting specific antibodies for the first 84 days of infection, with 57 of 60 (95%) serums tested being positive on the CF test and 57 of 57 (100%) tests being positive to the IFA test. During the interval from 98 to 175 days, 24 of 60 (40%) of the serums tested were positive with the CF test, and 53 of 56 (95%) were positive with the IFA test. During the first 84 days, a similar linear regression occurred in both CF and IFA serum titers, but after 98 days the IFA regression flattened out, whereas the CF titers decreased below the sensitivity threshold in 60% of the serums tested.

Entities:  

Mesh:

Year:  1977        PMID: 320922

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Serological prevalence of bovine babesiosis in Mali.

Authors:  D K Miller; O Diall; T M Craig; G G Wagner
Journal:  Trop Anim Health Prod       Date:  1984-05       Impact factor: 1.559

2.  A comparison of the complement fixation and immunofluorescent antibody tests in a survey of the prevalence of Babesia equi and Babesia caballi in horses in the Sultanate of Oman.

Authors:  J Donnelly; L P Joyner; O Graham-Jones; C P Ellis
Journal:  Trop Anim Health Prod       Date:  1980-02       Impact factor: 1.559

Review 3.  Diagnostic Tools for the Identification of Babesia sp. in Persistently Infected Cattle.

Authors:  J Antonio Alvarez; Carmen Rojas; Julio V Figueroa
Journal:  Pathogens       Date:  2019-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.